Russians created an anti-Hillary Clinton video game called "Hilltendo" and tried to make it go viral in the weeks before the 2016 U.S. presidential election, CNN has determined through a review of internet records and computer code.
It's one of the strangest ways yet discovered that Russians t
Please take note this is only one aspect in weighing the attractiveness or non-attractiveness of the companies mentioned as an investment and should not be used independent of other factors. This article examines one segment of the companies’ businesses, and other factors such as valuation are not addressed. This article is not a recommendation to buy or sell any stock mentioned.
American Express is joining the movement for expandedparental leave, and it’s doing so in a big way.
The credit card giant announced on Monday that it would be widening its parental leave program to now offer paid maternal or paternal leave for up to 20 weeks. Mothers who give birth and need additional medical leave will also be able to take another six to eight weeks before returning....More>>>
When fear and volatility rear their ugly heads, investors will traditionally turn to more conservative investments — such as gold. Presumably, this is what happened during the bitterly fought presidential campaign. In 2016, the price of gold, which ended the year up about 8%, had climbed as much as 28% at one point.
Similarly, many gold stocks enjoyed quite the ride last year —....More>>>
An East Coast blizzard hasn’t stopped the Federal Reserve from its two-day meeting.
A Fed rate hike is expected at the end of its widely watched meeting Wednesday. It would be the Fed’s second rate hike since December and a sign that the central bank’s leaders are moving interest rates up at a faster pace this year.
Alteryx (Pending:AYX) filed an S-1/A with the Securities and Exchange Commission for its upcoming initial public offering. The company intends to offer 9 million shares at a marketed price range of $12 to $14. Alteryx has an additional 1.35 million shares as an overallotment option for its underwriters. The underwriters for the IPO include Goldman, Sachs & Co. (NYSE:GS), JPMorgan (NYSE:JPM),....More>>>
My clear choice for a Top Pick for income investing is a closed-end fund that invests in a variety of both public and private companies doing work in the life sciences sector, asserts Nate Pile, editor of Nate’s Notes.
Tekla Life Sciences Investors (HQL) represents an outstanding way for investors who want to be involved in biotech, but don’t like the high levels of stress....More>>>
Big banks have gotten a boost today from JPMorgan Chase’s (JPM) dividend increase, and the hawkish Fed minutes, because higher rates are still expected to help banks out despite what happened last time. In a note previewing Wells Fargo’s (WFC) investor day on May 24, Jefferies analyst Ken Usdin and team write that “higher rates help, but other items weigh on longer-term net-interest-margin....More>>>
Shares of Kura Oncology (KURA) have risen by more than 90% since I presented the idea to readers in September of last year. The stock has climbed 38% since my update piece published in late November in which I stated my expectations of continued upside due to multiple clinical catalysts in 2018
In Lahore and Karachi, American flags were burned in front of TV cameras after President Trump’s decision on Jan. 4 to withhold $2 billion of security aid from Pakistan to punish it for allegedly harboring terrorists. The country’s government issued angry statements claiming no ins
AMGN,AVEO,BGNE,BMY,CELG,Deals and Financings,FPRX,TCON,TRXC,VTVT,ZLAB,
Nanjing Legend Biotech received a $350 million upfront payment from Janssen Biotech, which will form a global partnership with Legend for its highly effective CAR-T candidate. In June, Legend, which was not previously well known, surprised the annual ASCO meeting with stunningly positive results
Portola Pharmaceuticals (NASDAQ:PTLA) was one of the year's most hotly anticipated biotech IPOs when it was brought public by Morgan Stanley and Credit Suisse in May 2013 at $14.50/share. Shares quickly rose to the mid-$20s, but then did little afterwards for the next 18 months.